Literature DB >> 24259621

Treatment of Chryseobacterium indologenes ventilator-associated pneumonia in a critically ill trauma patient.

Megan R Monteen1, Supriya Ponnapula, G Christopher Wood, Martin A Croce, Joseph M Swanson, Bradley A Boucher, Timothy C Fabian.   

Abstract

OBJECTIVE: To report a case of Chryseobacterium indologenes ventilator-associated pneumonia (VAP) in a critically ill trauma patient. CASE
SUMMARY: This report describes a 66-year-old critically ill trauma patient who developed VAP, which was caused by C indologenes. The patient was injured in a riding lawn mower accident that trapped him underwater in a pond. The patient required surgery for intra-abdominal injuries and was mechanically ventilated in the trauma intensive care unit. On hospital day 5, the patient developed signs and symptoms of VAP. A diagnosis of C indologenes VAP was confirmed based on a quantitative culture from a bronchoscopic bronchoalveolar lavage. The patient's infection was successfully treated with moxifloxacin for 2 days followed by cefepime for 7 days. DISCUSSION: Formally known as Flavobacterium indologenes, C indologenes is a Gram-negative bacillus normally found in plants, soil, foodstuffs, and fresh and marine water sources. Recently, worldwide reports of C indologenes infections in humans have been increasing, though reports from the United States are still rare. Bacteremia and pneumonia are the most commonly reported infections, and most patients are immunocompromised. The current case differs from most previous reports because this patient was in the United States and did not have any traditional immunocompromised states (eg, transplant, cancer, HIV/AIDS, or corticosteroid use).
CONCLUSION: This case report demonstrates that C indologenes can cause VAP in a trauma ICU patient.

Entities:  

Keywords:  Chryseobacterium indologenes; critical illness; trauma; ventilator-associated pneumonia

Mesh:

Substances:

Year:  2013        PMID: 24259621     DOI: 10.1177/1060028013508745

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  7 in total

Review 1.  Chryseobacterium indologenes: an emerging infection in the USA.

Authors:  Ridhwi Mukerji; Radhika Kakarala; Susan Jane Smith; Halina G Kusz
Journal:  BMJ Case Rep       Date:  2016-04-06

2.  Chryseobacterium chengduensis sp. nov. isolated from the air of captive giant panda enclosures in Chengdu, China.

Authors:  Cai-Fang Wen; Li-Xin Xi; Shan Zhao; Zhong-Xiang Hao; Lu Luo; Hong Liao; Zhen-Rong Chen; Rong She; Guo-Quan Han; San-Jie Cao; Rui Wu; Qi-Gui Yan; Rong Hou
Journal:  J Zhejiang Univ Sci B       Date:  2016-08       Impact factor: 3.066

3.  A Case of Healthcare Associated Pneumonia Caused by Chryseobacterium indologenes in an Immunocompetent Patient.

Authors:  Salih Atakan Nemli; Tuna Demirdal; Serap Ural
Journal:  Case Rep Infect Dis       Date:  2015-01-06

4.  Chryseobacterium indologenes, a possible emergent organism resistant to carbapenem antimicrobials after stem cell transplantation.

Authors:  Osamu Imataki; Makiko Uemura
Journal:  Clin Case Rep       Date:  2016-12-15

5.  Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients.

Authors:  Vishwanath Singh Yadav; Bimal K Das; Hitender Gautam; Seema Sood; Arti Kapil; Sarita Mohapatra
Journal:  South Asian J Cancer       Date:  2018 Oct-Dec

6.  Pleural effusion due to Chryseobacterium indologenes: Case report and review of literature.

Authors:  Nazneen Arif; Swati Khullar; Ratnesh Kumar; Shiv Kumar Choudhary; Arti Kapil; Benu Dhawan
Journal:  J Lab Physicians       Date:  2019 Jul-Sep

7.  Chryseobacterium Indologenes Sepsis and Acute Renal Failure Secondary to Abdominal Compartment Syndrome in a Confirmed COVID-19 Patient.

Authors:  Alejandro José Quiroz Alfaro; Iván Javier Rodríguez Acosta; Mayumi Tanaka Takegami; Liliana Michelle Bracho Maya; Roberto Eduardo Quiroz Simanca
Journal:  Case Rep Crit Care       Date:  2022-04-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.